Le Lézard
Classified in: Health
Subjects: NPT, OBI

Pancreatic Cancer Action Network Advocate, Champion Charlotte Rae Dies


MANHATTAN BEACH, Calif., Aug. 6, 2018 /PRNewswire/ -- Charlotte Rae, an American TV actress, comedian, singer and Pancreatic Cancer Action Network (PanCAN) champion, has died. She was 92. No cause of death has been announced, but Rae publicly fought pancreatic cancer since 2009 and more recently, was diagnosed with bone cancer. 

Rae served as a Pancreatic Cancer Action Network (PanCAN) Influencer of Hope

Rae was known most notably for her portrayal of Edna Garrett (Mrs. Garrett) in the sitcoms "Diff'rent Strokes" and its spin-off, "The Facts of Life."

"In the pancreatic cancer community, Charlotte was a cherished champion for the cause," said Pamela Acosta Marquardt, PanCAN Founder. "She served as an Influencer of Hope, an elite group of notables who lend their voice and unite with everyday heroes in the fight against pancreatic cancer, and Charlotte was always willing to use her voice to raise awareness and visibility."

Pancreatic cancer was personal to Rae even before her own diagnosis. She lost three relatives to the disease, including her mother, uncle and older sister. Her extensive family history with pancreatic cancer led her to be more vigilant about the symptoms and risk factors associated with pancreatic cancer. 

"Keep searching for a solution, explore clinical trials," Rae told PanCAN in 2016 when asked what advice she gives other patients fighting the disease. "I'm extremely grateful to be here today and I'm sending out powerful prayers to all of you."

Not only did Rae use her voice on behalf of the world's toughest cancer, she attended local PurpleStride walks, championed for increased federal funding through PanCAN's annual National Pancreatic Cancer Advocacy Day in Washington, D.C., and referenced the organization in numerous media interviews.

"We must speak out loud and clear: Federal funds must be invested to develop more effective treatments and to find a simple, affordable detection test," Rae told fellow PanCAN Advocacy Day participants in a letter she penned in 2013. "This disease is so frightening because it cannot be detected early enough. Effective treatments and early detection tools could save thousands and thousands of lives."

On behalf of Rae and all patients like her, PanCAN will continue to work diligently to double survival and improve patient outcomes.

Learn more about the Pancreatic Cancer Action Network by visiting pancan.org. Follow the Pancreatic Cancer Action Network on TwitterInstagram and Facebook

About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world's toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.

Media Contact:
Cara Martinez
Associate Director, Communications
Pancreatic Cancer Action Network
Direct: 310-706-3357 | E-mail: [email protected]

 

Rae with fellow survivors at the Pancreatic Cancer Action Network (PanCAN) PurpleStride Orange County 2016

The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world's toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve outcomes today and to double survival by 2020. (PRNewsfoto/Pancreatic Cancer Action Network)

SOURCE Pancreatic Cancer Action Network


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: